422 related articles for article (PubMed ID: 30102240)
21. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
22. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
23. Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver.
Carabe A; España S; Grassberger C; Paganetti H
Phys Med Biol; 2013 Apr; 58(7):2103-17. PubMed ID: 23470339
[TBL] [Abstract][Full Text] [Related]
24. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
Bertolet A; Carabe A
Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
[TBL] [Abstract][Full Text] [Related]
25. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
[TBL] [Abstract][Full Text] [Related]
26. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning.
McMahon SJ; Paganetti H; Prise KM
Phys Med Biol; 2018 Nov; 63(22):225009. PubMed ID: 30412471
[TBL] [Abstract][Full Text] [Related]
27. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
28. Range uncertainty in proton therapy due to variable biological effectiveness.
Carabe A; Moteabbed M; Depauw N; Schuemann J; Paganetti H
Phys Med Biol; 2012 Mar; 57(5):1159-72. PubMed ID: 22330133
[TBL] [Abstract][Full Text] [Related]
29. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
31. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
32. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
Ödén J; Eriksson K; Toma-Dasu I
Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
[TBL] [Abstract][Full Text] [Related]
33. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
34. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
35. A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.
Rørvik E; Thörnqvist S; Stokkevåg CH; Dahle TJ; Fjaera LF; Ytre-Hauge KS
Med Phys; 2017 Jun; 44(6):2586-2594. PubMed ID: 28295379
[TBL] [Abstract][Full Text] [Related]
36. Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak.
Marshall TI; Chaudhary P; Michaelidesová A; Vachelová J; Davídková M; Vondráček V; Schettino G; Prise KM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):70-77. PubMed ID: 27084630
[TBL] [Abstract][Full Text] [Related]
37. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
Grün R; Friedrich T; Traneus E; Scholz M
Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
[TBL] [Abstract][Full Text] [Related]
38. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
Grün R; Friedrich T; Krämer M; Scholz M
Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
[TBL] [Abstract][Full Text] [Related]
39. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]